Clovis Oncology Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock

Thursday, 5 January 2017
BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ:CLVS) announced today that the underwriters of its recently announced public offering of its common stock have exercised in full their option to purchase an additional 750,000 shares. The offering, including the sale of the additional shares, is expected to close on January 9, 2017, subject to customary closing conditions. Clovis Oncology intends to use the net proceeds of the offering for general corporate purposes, including comme

Recent related news

Advertisement
HOUSTON, TX--(Marketwired - May 17, 2017) - Tellurian Inc. (Tellurian or the Company) (NASDAQ: TELL) today announced that it intends to offer for sale 10,000,000...
5 days ago • Marketwired
MONACO, May 15, 2017 - GasLog Partners LP ("GasLog Partners", the "Partnership" or "we") (NYSE: GLOP) announced today the closing of its public offering of...
1 week ago • GlobeNewswire
G1 Therapeutics, Inc., a clinical-stage oncology company, announced late Tuesday the pricing of its initial public offering of 7 million shares of common stock...
6 days ago • RTTNews
EL PASO, Texas--(BUSINESS WIRE)--Helen of Troy Limited (NASDAQ, NM: HELE), designer, developer and worldwide marketer of consumer brand-name housewares, health...
1 week ago • Business Wire
NEW YORK--(BUSINESS WIRE)--Western Asset Middle Market Income Fund Inc. (XWMFX) announced today that the Fund’s Board of Directors has approved a tender offer...
1 week ago • Business Wire
NEW YORK--(BUSINESS WIRE)--Western Asset Middle Market Debt Fund Inc. (XWAMX) announced today that the Fund’s Board of Directors has approved a tender offer...
1 week ago • Business Wire

You might like